The Mechanism of Human Bladder Tumor Implantation in an in Vitro Model-Reference-Cited by-同舟云学术

The Mechanism of Human Bladder Tumor Implantation in an in Vitro Model

Published:1986-08 Issue:2 Volume:136 Page:482-486
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Pode Dov¹,Alon Yaakov¹,Horowitz Aviva T.¹,Vlodavsky Israel¹,Biran Shoshana¹

Affiliation:

1. From the Department of Urology, the Department of Cancer Research and the Department of Radiation and Clinical Oncology, Hebrew University-Hadassah Medical School, Jerusalem, Israel

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference23 articles.

1. Benign papilloma or papillary carcinoma of the bladder;Greene;J. Urol.,1973

2. Tumors of the urinary bladder: a pathological and clinical solution of 434 cases;Frankson;Acta Chir. Scand.,1950

3. The surgical spread of cancer in urology;Boreham;Br. J. Urol.,1956

4. Dissemination of bladder neoplasms by endoscopic electrocoagulation;Weyranch;J. Urol.,1962

5. Bladder tumor recurrence in the urethra; a warning;Kiefer;J. Urol.,1953

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sterile Water Versus Glycine in Transurethral Resection of Bladder Tumors—Immunogenic and Clinical Implications;European Urology Focus;2024-03

2. Initial experience with surrounding en bloc transurethral resection of bladder tumor and simultaneous intravesical treating for non-muscle invasive bladder cancer;BMC Urology;2022-11-23

3. Oncological safety of simultaneous transurethral resection of high-grade urothelial carcinoma of the bladder and benign prostatic hyperplasia;Arab Journal of Urology;2022-11-11

4. Assessment of Therapeutic Benefit and Option Strategy on Intravesical Instillation for Preventing Bladder Cancer Recurrence after Radical Nephroureterectomy in Patients with Upper Urinary Tract Urothelial Carcinoma;Journal of Oncology;2022-05-30

5. Single immediate instillation of chemotherapy is associated with decreased recurrence and progression in patients with high‐risk non‐muscle‐invasive bladder cancer who receive adjuvant induction bacillus Calmette‐Guérin therapy;International Journal of Urology;2022-05-16